VB

Vinodkumar Bhikhabhai Loh

Active Director Director DIN 05103042
DIN 05103042 First appointment May 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Vinodkumar Bhikhabhai Loh

Data last updated:

Vinodkumar Bhikhabhai Loh is a Director at Hagios Life Sciences Private Limited (since 2014). The company operates in Pharma.

DIN 05103042
Primary Designation Director
Industry Pharma
First Appointment 31 May 2014
Oldest Company Age 14 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hagios Life Sciences Private Limited U51397GJ2011PTC068325
Director31 May 20142011Active

Board colleagues of Vinodkumar Bhikhabhai Loh

Directorship timeline

Open interactive timeline →
Hagios Life Sciences Private Limited
Premium access

Shareholding and investment profile for Vinodkumar Bhikhabhai Loh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vinodkumar Bhikhabhai Loh

Vinodkumar Bhikhabhai Loh currently holds 1 directorship: Hagios Life Sciences Private Limited (Director, since 31 May 2014).

Vinodkumar Bhikhabhai Loh was first appointed on 31 May 2014 as Director at Hagios Life Sciences Private Limited.

The current boards of Vinodkumar Bhikhabhai Loh's companies include Dineshkumar Laxmanbhai Chaudhary (Hagios Life Sciences Private Limited), Pravinkumar Hemtabhai Chaudhary (Hagios Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available